Beyond Selling Value
Autor Mark Shonka, Dan Koschen Limba Engleză Paperback – 22 oct 2012
Selling value is taking on a whole new meaning for sales professionals. Here's a proven process pros can use to address their customer's pressing business issues, position themselves as strategic partners, and recommend solutions that improve the way their customers do business.
In Beyond Selling Value, top sales consultants Mark Shonka and Dan Kosch share their proven process for becoming a critical partner in their customers' success. From targeting the most promising prospects, to bypassing the gatekeepers, to reaching the decision makers who are empowered to buy, and to closing the deal with a powerful presentation, the authors impart their battle tested secrets to forging long term business relationships.
For sales professionals tired of being beaten up on price, here is a new way to leverage their strengths, elevate their sales game, and establish relationships with those who appreciate their value. Selling Power magazine calls it "a detailed, street smart roadmap".
Preț: 80.97 lei
Preț vechi: 109.64 lei
-26%
Puncte Express: 121
Preț estimativ în valută:
15.51€ • 16.80$ • 13.30£
15.51€ • 16.80$ • 13.30£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780793154708
ISBN-10: 0793154707
Pagini: 304
Dimensiuni: 152 x 229 x 15 mm
Greutate: 0.4 kg
Editura: Kaplan Test Prep
Colecția Kaplan Test Prep
Locul publicării:United States
ISBN-10: 0793154707
Pagini: 304
Dimensiuni: 152 x 229 x 15 mm
Greutate: 0.4 kg
Editura: Kaplan Test Prep
Colecția Kaplan Test Prep
Locul publicării:United States
Notă biografică
Together, authors and IMPAX Corporation copresidents Mark Shonka and Dan Kosch have tallied more than 40 years experience in direct sales, sales management, and sales consulting and training. IMPAX has worked with thousands of sales professionals throughout North America and abroad at companies including IBM, DuPont, AT&T, Eli Lilly, and Microsoft.